Corporate Banner
Satellite Banner
Immunology
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Merck Millipore Introduces PureEpi™ Chromatin Preparation and Optimization Kit

Published: Thursday, May 23, 2013
Last Updated: Thursday, May 23, 2013
Bookmark and Share
Optimized for preparation of chromatin samples specifically for the Chromatin Immunoprecipitation (ChIP) application.

Merck Millipore has introduced the PureEpi™ Chromatin Preparation and Optimization Kit. The PureEpi™ kit provides a systematic approach to address the technical challenges of optimizing the preparation of chromatin by providing a complete set of validated reagents specifically designed for the generation of chromatin for ChIP experiments.

The materials provided in this kit are ideal for both the optimization of chromatin preparations, as well as the generation of chromatin in multiple sample types starting from either cultured cells or tissues.

"ChIP and ChIP-seq are two very powerful techniques used to study how changes in chromatin structure impact gene expression. The successful performance of these techniques relies on high quality chromatin to produce meaningful data," says Michael Sturges, Ph.D., Senior Product Manager, Epigenetics, Merck Millipore.

Sturges continued, "New users of the ChIP application often struggle initially to establish reliable working protocols for chromatin preparation. For many laboratories, the chromatin preparation step of ChIP can be technically demanding, as it requires accounting for multiple variables that are unique to each experimental situation. Any lab that needs a reliable and reproducible approach to generate high quality chromatin that gives the best possible ChIP signal will benefit from the PureEpi™ kit."

During development of the PureEpi™ kit, the R&D team at Merck Millipore conducted numerous experiments to explore how different variables in chromatin preparation impact a ChIP experiment.

Parameters such as chromatin size, input cell numbers, fixation, sonication, and sample type all impact the quality of the chromatin and consequently the ChIP data.

The protocols and reagents developed as a result of this investigation have been incorporated into these kits to enable any lab to establish conditions that generate highly ChIPable chromatin.

While other kits enable extraction of chromatin from cells, this is the first kit to provide a set of buffers, detailed methods and optimization guidelines specifically designed for generation of sheared chromatin for ChIP.

The protocol provided in the kit outlines a standard approach for chromatin preparation and includes tips to avoid common pitfalls.

Additional sections with data demonstrating how modifications to key parameters such as fixation and sonication conditions impact chromatin quality and ChIP performance are presented to help guide optimization for more challenging experiments.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Merck Millipore Announces Agreement with Precision Biologics
Merck Millipore services include design and development of cost-effective process to deliver high yield and productivity.
Thursday, February 05, 2015
Merck Millipore Partners with Gyros
Partnership to develop, manufacture and commercialize kits on the Gyrolab™ immunoassay platform.
Tuesday, July 16, 2013
Merck Millipore Announces Partnership with NIH Consortium
Adds more than 140 peer-validated neuroscience-specific monoclonal antibodies to portfolio.
Tuesday, October 16, 2012
Scientific News
Health Risks of Saturated Fats Aggravated by Immune Response
Research shows that the presence of saturated fats resulted in monocytes migrating into the tissues of vital organs.
Inciting an Immune Attack On Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
Inciting an Immune Attack on Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
Inflammation Linked to Colon Cancer Metastasis
A new Arizona State University research study led by Biodesign Institute executive director Raymond DuBois has identified for the first time the details of how inflammation triggers colon cancer cells to spread to other organs, or metastasize.
New Strategy for Combating Adenoviruses
Using an animal model they developed, Saint Louis University and Utah State university researchers have identified a strategy that could keep a common group of viruses called adenoviruses from replicating and causing sickness in humans.
Major Advance Toward More Effective, Long-Lasting Flu Vaccine
Collaboration shows vaccine candidate can produce powerful ‘broadly neutralizing antibodies’ in animal models.
Immune System: Help for Killer Cells
A study from the University of Bonn may show the way to more effective vaccines.
Protein Found to Control Inflammatory Response
A new Northwestern Medicine study shows that a protein called POP1 prevents severe inflammation and, potentially, diseases caused by excessive inflammatory responses.
A Leap Forward in Vaccinating Against HIV
A team of scientists has developed an experimental vaccine candidate that successfully stimulates the immune system activity in animal models necessary to stop HIV infection.
MRI Scanners Can Steer Therapeutics to Specific Target Sites
Scientists from the University of Sheffield have discovered MRI scanners, normally used to produce images, can steer cell-based, tumour busting therapies to specific target sites in the body.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!